Frontlight ResearchEarly access
Trial site
Kaiser Permanente Riverside Medical Center
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration3 trials
- Stroke2 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Ovarian cancer1 trial
- Phase
- Phase 39 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Recruiting5 trials
- Active, not recruiting4 trials
- Completed2 trials
- Lead sponsor
- Joseph Broderick, MD2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- 4D Molecular Therapeutics1 trial
- Astellas Institute for Regenerative Medicine1 trial
- AVEO Pharmaceuticals, Inc.1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Recruiting
Recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration2 recruiting
- Bladder cancer1 recruiting
- Melanoma1 recruiting
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026